AirSeal Named Finalist in Global Impact Award by Skandalaris - AirSeal CardioVascular

AirSeal Named Finalist in Global Impact Award by Skandalaris

Releted Post

AirSeal is selected as a recipient of the first WashU Venture Network Follow-on Investments

April 12, 2025

Our co-founder, Dr. Zayed, was recently interviewed by KMOX Radio

April 1, 2025

AirSeal is awarded a co-investment of $500,000 from Missouri Technology Corporation (MTC)

November 12, 2024

AirSeal is selected as a 2024 Arch Grants recipient, which includes a $75,000 non-dilutive cash award.

November 1, 2024

AirSeal is one of the six finalists of the Global Impact Award (GIA) competition held by the Skandalaris Center of Washington University.

https://skandalaris.wustl.edu/blog/2023/01/30/skandalaris-announces-six-finalists-for-the-2023-global-impact-award/

AirSeal is advancing early, accurate diagnosis of cardiovascular diseases through innovative biomarker technology.

© 2023-2025 by AirSeal CardioVascular Inc. Designed & Developed by Steatech